Extended Window for Stroke Clot Removal Shows Promise and Risks

When a person experiences an acute ischemic stroke, emergency physicians typically race against a strict clock. Restoring blood flow to the brain as quickly as possible is vital to prevent permanent tissue damage or death. Endovascular thrombectomy, a minimally invasive procedure that physically removes clots from major blocked blood vessels, has long served as a standard emergency intervention within the first 24 hours of symptom onset.

Evaluating the 24-Hour Threshold

However, many patients arrive at medical centers well past this initial 24-hour window. Previously, doctors lacked robust randomized trial data to determine whether performing a mechanical thrombectomy days later could safely and effectively aid recovery, or if the intervention would expose patients to heightened risks. To address this clinical uncertainty, researchers designed the LATE-MT trial to investigate whether delayed clot removal could still salvage oxygen-deprived brain tissue.

Published in the New England Journal of Medicine, the prospective, randomized controlled trial evaluated adult patients across 35 stroke centers in China. The study enrolled 336 eligible participants who had suffered an ischemic stroke due to a major blocked blood vessel. Investigators divided the cohort into two equal groups. One group received guideline-based medical care combined with mechanical thrombectomy performed between 24 and 72 hours after the initial appearance of symptoms. The control group received standard stroke medications, which included oral antiplatelet drugs and treatments to manage brain swelling, alongside routine hospital support.

Functional Recovery Outcomes at 90 Days

At the 90-day mark, researchers assessed patient outcomes using the modified Rankin Scale, which measures post-stroke disability and the ability to manage daily activities. The findings revealed that approximately 49% of the patients who underwent the delayed thrombectomy procedure achieved functional independence and were able to live on their own, compared to 35% of those who received standard medical management alone.

Furthermore, about 26.9% of patients in the thrombectomy group experienced no significant disability despite retaining some residual symptoms, contrasted with 15.6% in the control group. Treated participants also reported improvements in their overall quality of life.

Weighing Procedural Risks

Despite the favorable functional recovery statistics, the study highlighted important safety trade-offs associated with performing mechanical thrombectomy beyond the standard 24-hour timeframe. The intervention carried elevated risks of severe complications. Symptomatic intracranial hemorrhage, defined as bleeding inside the brain that causes clinical symptoms, occurred in 4.8% of the patients who underwent thrombectomy. In contrast, no cases of symptomatic brain bleeding were observed in the control group receiving medication alone.

Additionally, the 90-day mortality rate was higher among participants in the thrombectomy arm, standing at 6.0% compared with 1.8% in the standard care group.

Implications for Clinical Practice

The findings from the LATE-MT trial suggest that clinicians should not automatically dismiss patients who arrive at the hospital more than 24 hours after a stroke. Instead, medical specialists may need to evaluate selected individuals carefully, balancing the potential presence of salvageable brain tissue against the documented risks of delayed intervention.

• Thrombectomy performed 24 to 72 hours post-stroke improved independent living outcomes at 90 days.
• Symptomatic intracranial hemorrhage and 90-day mortality rates were higher in the thrombectomy group.
• Specialists emphasize individualized patient assessment rather than rigid time cutoffs alone.